Nevertheless, a detailed analysis of the effects of NLRP3 variants on NLRP3-inflammasome activity and on IL-1β cytokine levels in IBD patients is necessary, before considering NLRP3 variant data for treatment decisions. This evidence concerns the gene NLRP3 and inflammatory bowel disease.